Results
|
|
3901.
|
Sorafenib inhibits transforming growth factor β1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes. [electronic resource] by
- Chen, Yue-Lei
- Lv, Jing
- Ye, Xiao-Lei
- Sun, Ming-Yu
- Xu, Qin
- Liu, Cheng-Hai
- Min, Li-Hua
- Li, Hui-Ping
- Liu, Ping
- Ding, Xiaoyan
Producer: 20110719
In:
Hepatology (Baltimore, Md.) vol. 53
Availability: No items available.
|
|
|
3902.
|
|
|
|
3903.
|
|
|
|
3904.
|
|
|
|
3905.
|
|
|
|
3906.
|
|
|
|
3907.
|
|
|
|
3908.
|
|
|
|
3909.
|
|
|
|
3910.
|
|
|
|
3911.
|
|
|
|
3912.
|
|
|
|
3913.
|
Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794]. [electronic resource] by
- Hoffmann, K
- Glimm, H
- Radeleff, B
- Richter, G
- Heining, C
- Schenkel, I
- Zahlten-Hinguranage, A
- Schirrmacher, P
- Schmidt, J
- Büchler, M W
- Jaeger, D
- von Kalle, C
- Schemmer, P
Producer: 20090807
In:
BMC cancer vol. 8
Availability: No items available.
|
|
|
3914.
|
|
|
|
3915.
|
|
|
|
3916.
|
|
|
|
3917.
|
|
|
|
3918.
|
|
|
|
3919.
|
|
|
|
3920.
|
|